Trial Profile
A randomized, double-blind, placebo-controlled, comparative study of HP-3000 in patients with Parkinson's disease taking L-DOPA
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2016
Price :
$35
*
At a glance
- Drugs Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 02 Feb 2015 New trial record